Ursodeoxycholic Acid in pharma franchise in Arunachal Pradesh

Ursodeoxycholic Acid in PCD pharma franchise in Shimla

Ursodeoxycholic Acid in top pharma company in Tiruchirappalli

Ursodeoxycholic Acid in pcd pharma supplier in Mysore

Ursodeoxycholic Acid in phama franchise company in India
Ursodeoxycholic Acid in phama distributor in Belagavi

Home/Products /ursodeoxycholic-acid-300mg-tablet

Uriviga 300 Tablet

Composition : Ursodeoxycholic Acid (300mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*1*10

Price : ₹390/-

Uriviga 300 Tablet contains Ursodeoxycholic Acid, a bile acid used primarily in the treatment of various liver and gallbladder disorders. It is effective in dissolving cholesterol gallstones and improving bile flow. Ursodeoxycholic acid helps to reduce the concentration of cholesterol in bile, preventing the formation of new gallstones and promoting the dissolution of existing cholesterol stones. Additionally, it is beneficial in managing conditions like primary biliary cirrhosis, where it helps improve liver function by slowing disease progression and reducing symptoms such as fatigue and itching.

The medication works by enhancing the solubility of cholesterol in bile and preventing the accumulation of harmful substances in the liver. Uriviga 300 Tablet is commonly prescribed to patients with non-alcoholic fatty liver disease (NAFLD), liver damage, and those undergoing gallstone management. It helps in improving liver function, reducing bile acid buildup, and maintaining gallbladder health.

Read More

About the Product

Uriviga 300 Tablet contains Ursodeoxycholic Acid, a bile acid used primarily in the treatment of various liver and gallbladder disorders. It is effective in dissolving cholesterol gallstones and improving bile flow. Ursodeoxycholic acid helps to reduce the concentration of cholesterol in bile, preventing the formation of new gallstones and promoting the dissolution of existing cholesterol stones. Additionally, it is beneficial in managing conditions like primary biliary cirrhosis, where it helps improve liver function by slowing disease progression and reducing symptoms such as fatigue and itching.

The medication works by enhancing the solubility of cholesterol in bile and preventing the accumulation of harmful substances in the liver. Uriviga 300 Tablet is commonly prescribed to patients with non-alcoholic fatty liver disease (NAFLD), liver damage, and those undergoing gallstone management. It helps in improving liver function, reducing bile acid buildup, and maintaining gallbladder health.

Common side effects include diarrhea, nausea, abdominal discomfort, and headache. Serious side effects, such as liver dysfunction, may require immediate medical attention.

Uriviga 300 Tablet is indicated for the treatment of cholesterol gallstones, primary biliary cirrhosis, non-alcoholic fatty liver disease (NAFLD), and other liver-related conditions.

Consult your doctor before use if you have a history of liver disease or are allergic to Ursodeoxycholic acid. Not recommended for patients with active liver disease.

Store in a cool, dry place at room temperature. Keep away from heat and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation